Tetracore, Inc., and VMRD, Inc., announced today that Tetracore's animal health products have been purchased by VMRD. A complete list of products is available below. Both organizations are working closely to ensure this transition is smooth and supported for customers. Product descriptions, catalog numbers, and performance characteristics will remain the same. “Our shared priority is the customer experience,” said JJ McCallie, Vice President of Products. “We are committed to delivering the …
Convergence Healthcare Advisors serves as exclusive advisor to NIRvana Sciences in its sale to Waters Biosciences (formerly Becton Dickinson Biosciences)
NIRvana Sciences, a research-based startup with origins in the lab of professor Jonathan Lindsey, was acquired by the global leading life sciences company in 2025. NIRvana Sciences, a startup company commercializing synthetic red and near-infrared fluorescent dyes for use in diagnostics and imaging, has been acquired by Waters Biosciences, a global leader in life sciences and diagnostics. The startup was acquired by Waters in May 2025 to expand the company’s portfolio of high-performance fluorescent dyes used in flow cytometry and other biomedical applications. NIRvana Sciences — …
Anodyne completes sale of Majority Equity Stake to HealthEdge Investment Partners.
April 25, 2022 – HealthEdge Investment Partners, LLC (“HealthEdge”), a healthcare focused private equity fund, announced today that it has completed an investment in Anodyne, LLC (“Anodyne”), a leading provider of lifestyle-oriented clinical footwear solutions most commonly prescribed for diabetic patients. Anodyne was founded in 2015 by a group of industry executives who set out to reimagine the diabetic footwear market and establish a new, leading brand—one that would offer patients a variety of modern and stylish shoe selections and suppliers an unmatched service experience. Over the …
Convergence Healthcare Advisors serves as strategic adviser to Humanscale in the sale of Humanscale Healthcare to Capsa Healthcare
Capsa Healthcare, a leading innovator in healthcare delivery solutions for hospitals, long-term care, and retail pharmacy providers, announced the acquisition of Humanscale Healthcare, a designer and manufacturer of flexible technology solutions and computing workstations based in New York, NY. Capsa’s purchase of Humanscale Healthcare is the company’s seventh major brand acquisition in the last 11 years. With 50+ years of product innovation experience, Capsa has grown steadily through a combination of internal development and acquisition of complementary product brands and technology …
Convergence Healthcare Advises Horizon Discovery in the divestiture of its Animal Research Models business to Envigo
Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global leader in the application of gene editing and gene modulation technologies, today announces an agreement to divest the Group’s animal research models business unit (“the business unit”) to Envigo RMS LLC (“Envigo”). The divestment forms part of Horizon’s strategy to refocus on high growth areas within its ore market and is expected to be completed within 30-45 days, subject to customary closing conditions. Already a well-established supplier of gene editing and gene modulation reagents, libraries and …
Convergence Healthcare Advisors served as exclusive strategic advisor to Natera, Inc. on the sale of the Evercord business to CBR.
LOS ANGELES, Sept. 13, 2019 /PRNewswire/ — CBR (Cord Blood Registry), the world’s largest newborn stem cell collection and storage company, today announced the asset acquisition of Natera, Inc.’s (NASDAQ: NTRA) Evercord™ newborn stem cell business. The mutually beneficial move brings together two of the industry’s most respected newborn stem cell storage companies. “As a pillar of the California Cryobank Life Sciences (CCLS) organization, CBR is built on scientific excellence, leadership, and best-in-class services,” said Richard Jennings, California Cryobank Life Sciences, CEO. …